SCWorx Corp has developed and markets health information technology solutions and associated services that improve healthcare processes and information flow within hospitals. Its software platform enables healthcare providers to simplify, repair, and organize its data, allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics. The company's solutions are designed to improve the flow of information quickly and accurately between the existing supply chain, electronic medical records, clinical systems, and patient billing functions. It operates in a single segment - health information technology solutions and services, located in a single geographic location - the United States.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$1.09 – $1.18
Volume49,154
Market cap$0M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$103.26K
Price / earnings
—
Price / book
0.01×
Price / sales
0.04×
EV / sales
-0.4×
EV / EBITDA
7.27×
Profitability
Earnings per share
-$26.24
Return on assets
-30.57%
Return on equity
-33.99%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
2.19×
Quick ratio
2.19×
Cash ratio
1.63×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$756.22K
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for WORX, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$706.05K
$744.9K
$768.9K
$705.8K
$682.63K
$720.3K
$675.75K
$759.72K
Cost of revenue
$375.63K
$370.79K
$418.4K
$453.87K
$502.22K
$583.44K
$517.3K
$627.15K
Gross profit
$330.42K
$374.11K
$350.5K
$251.93K
$180.42K
$136.86K
$158.45K
$132.58K
Selling, general and administrative
$326.33K
$350.68K
$542.43K
$390.78K
$362.61K
$266.88K
$538.77K
$526.07K
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$451.38K
$509.92K
$1.04M
$390.78K
$473.94K
$470.86K
$311.37K
$526.07K
Operating income
-$120.95K
-$135.81K
-$692.13K
-$138.86K
-$293.53K
-$334K
-$152.92K
-$393.5K
Interest expense
$0
-$37.95K
-$135.16K
-$1.17M
-$1.53M
-$142.31K
-$42.37K
-$31.47K
Income before taxes
-$120.95K
-$173.77K
-$749.18K
-$1.31M
-$1.91M
-$476.3K
-$195.29K
-$424.96K
Income taxes
$0
$0
$0
$0
$0
$0
$0
$0
Net income
-$120.95K
-$173.77K
-$749.18K
-$1.31M
-$1.91M
-$476.3K
-$195.29K
-$424.96K
Net income attributable to common shareholders
-$120.95K
-$173.77K
-$749.18K
-$1.31M
-$1.91M
-$476.3K
-$195.29K
-$424.96K
EBITDA
$4.1K
$23.43K
-$48.35K
-$138.86K
-$182.19K
-$130.02K
-$152.92K
-$393.5K
Basic earnings per share
-$1.35
-$0.16
-$0.77
-$2.25
-$82.27
-$3.71
-$1.69
-$4.05
Diluted earnings per share
-$1.35
-$0.16
-$0.77
-$2.25
-$82.27
-$3.71
-$1.69
-$4.05
Recent news
Company coverage with links to the original publishers.
SCWorx Corp. received approval from the Nasdaq Hearings Panel to continue its Nasdaq listing after trading was suspended in April 2026 for failing to meet the $1.00 minimum bid price requirement. The company must obtain shareholder approval for a reverse stock split by July 22, 2026, execute the split by August 3, 2026, and demonstrate compliance with the bid price rule by August 28, 2026. Failure to meet these conditions will result in delisting to OTC Markets.
SCWorx Corp. signed a new agreement with a leading healthcare supply chain partner, expanding its SaaS data management program to help hospitals optimize procurement and reduce costs.
The global combination saw market is expected to grow at a CAGR of 6.4% from 2025 to 2035, driven by the increasing demand for automated saws across various industries, emphasis on workplace safety, and technological advancements.
SCWorx Corp, a healthcare software company, has completed a $200,000 equity financing with institutional investors. The company plans to use the proceeds for working capital and general corporate purposes to support its future growth.
NEW YORK, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- On May 17, 2024, SCWorx Corp. (the “Company”) received a further notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Form 10-Q for the period ended March 31, 2024, and because it remains delinquent in filing its Form 10-K for the year ended December 31, 2023, the Company has failed to satisfy a standard for continued listing, namely Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic reports with the SEC.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.